Zelalem Eshete

Array ( [id] => 6575867 [patent_doc_number] => 20100273765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'Rifamycin analogs and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/821368 [patent_app_country] => US [patent_app_date] => 2007-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32668 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0273/20100273765.pdf [firstpage_image] =>[orig_patent_app_number] => 11821368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 582835 [patent_doc_number] => 07449455 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-11 [patent_title] => '2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents' [patent_app_type] => utility [patent_app_number] => 11/820735 [patent_app_country] => US [patent_app_date] => 2007-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36373 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/449/07449455.pdf [firstpage_image] =>[orig_patent_app_number] => 11820735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6275361 [patent_doc_number] => 20100256082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'Metallo-hydrolase inhibitors using metal binding moietes in combination with targeting moieties' [patent_app_type] => utility [patent_app_number] => 12/310709 [patent_app_country] => US [patent_app_date] => 2007-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 29570 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256082.pdf [firstpage_image] =>[orig_patent_app_number] => 12310709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7724341 [patent_doc_number] => 08097612 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-17 [patent_title] => 'Compositions and methods relating to novel compounds and targets thereof' [patent_app_type] => utility [patent_app_number] => 12/303272 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23540 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/097/08097612.pdf [firstpage_image] =>[orig_patent_app_number] => 12303272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4534482 [patent_doc_number] => 07888345 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-15 [patent_title] => 'Benzaepinones as sodium channel blockers' [patent_app_type] => utility [patent_app_number] => 12/308209 [patent_app_country] => US [patent_app_date] => 2007-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21037 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/888/07888345.pdf [firstpage_image] =>[orig_patent_app_number] => 12308209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7535380 [patent_doc_number] => 08049006 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-01 [patent_title] => '7-membered ring compound and method of production and pharmaceutical application thereof' [patent_app_type] => utility [patent_app_number] => 12/302646 [patent_app_country] => US [patent_app_date] => 2007-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 116637 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/049/08049006.pdf [firstpage_image] =>[orig_patent_app_number] => 12302646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5247853 [patent_doc_number] => 20070244087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => '2-ALKOXY-3,4,5-TRIHYDROXY-ALKYLAMIDES, PREPARATION THEREOF, COMPOSITIONS CONTAINING THEM AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 11/753160 [patent_app_country] => US [patent_app_date] => 2007-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23814 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244087.pdf [firstpage_image] =>[orig_patent_app_number] => 11753160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5211000 [patent_doc_number] => 20070249584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'BENGAMIDES WITH A SUBSTITUTED CAPROLACTAME CYCLE, METHOD FOR THE PREPARATION THEREOF, COMPOSITIONS CONTAINING THEM AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 11/753154 [patent_app_country] => US [patent_app_date] => 2007-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11542 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20070249584.pdf [firstpage_image] =>[orig_patent_app_number] => 11753154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4514950 [patent_doc_number] => 07910578 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-22 [patent_title] => '8,10-diaza-bicyclo[4.3.1]decane derivatives and their medical use' [patent_app_type] => utility [patent_app_number] => 12/298290 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5337 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/910/07910578.pdf [firstpage_image] =>[orig_patent_app_number] => 12298290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5502790 [patent_doc_number] => 20090163478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Salts and Crystal Modifications Thereof' [patent_app_type] => utility [patent_app_number] => 12/298203 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4478 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20090163478.pdf [firstpage_image] =>[orig_patent_app_number] => 12298203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5126476 [patent_doc_number] => 20070238747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Rifamycin analogs and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/804141 [patent_app_country] => US [patent_app_date] => 2007-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16365 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20070238747.pdf [firstpage_image] =>[orig_patent_app_number] => 11804141 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7691439 [patent_doc_number] => 20070232594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both' [patent_app_type] => utility [patent_app_number] => 11/803187 [patent_app_country] => US [patent_app_date] => 2007-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58049 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232594.pdf [firstpage_image] =>[orig_patent_app_number] => 11803187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6302308 [patent_doc_number] => 20100068203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => '17-Oxymacbecin Derivatives and Their Use in the Treatment of Cancer and/or B-Cell Malignancies' [patent_app_type] => utility [patent_app_number] => 12/296537 [patent_app_country] => US [patent_app_date] => 2007-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17719 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068203.pdf [firstpage_image] =>[orig_patent_app_number] => 12296537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 204791 [patent_doc_number] => 07629338 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-08 [patent_title] => 'Substituted monocyclic CGRP receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/800626 [patent_app_country] => US [patent_app_date] => 2007-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58571 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/629/07629338.pdf [firstpage_image] =>[orig_patent_app_number] => 11800626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5016641 [patent_doc_number] => 20070259850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'CONSTRAINED COMPOUNDS AS CGRP-RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 11/742615 [patent_app_country] => US [patent_app_date] => 2007-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43830 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259850.pdf [firstpage_image] =>[orig_patent_app_number] => 11742615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5016642 [patent_doc_number] => 20070259851 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'CONSTRAINED COMPOUNDS AS CGRP-RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 11/742626 [patent_app_country] => US [patent_app_date] => 2007-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57743 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259851.pdf [firstpage_image] =>[orig_patent_app_number] => 11742626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4705162 [patent_doc_number] => 20080064686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'Novel soluble 1,4 benzodiazepine compounds and stable salts thereof' [patent_app_type] => utility [patent_app_number] => 11/796039 [patent_app_country] => US [patent_app_date] => 2007-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24335 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064686.pdf [firstpage_image] =>[orig_patent_app_number] => 11796039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 250891 [patent_doc_number] => 07582647 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-01 [patent_title] => 'Carboxylic acid derivatives, their preparation and use' [patent_app_type] => utility [patent_app_number] => 11/789630 [patent_app_country] => US [patent_app_date] => 2007-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10861 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/582/07582647.pdf [firstpage_image] =>[orig_patent_app_number] => 11789630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7967171 [patent_doc_number] => 07939657 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'N-substituted benzene sulfonamides' [patent_app_type] => utility [patent_app_number] => 11/738863 [patent_app_country] => US [patent_app_date] => 2007-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43983 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939657.pdf [firstpage_image] =>[orig_patent_app_number] => 11738863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 202728 [patent_doc_number] => 07632829 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-15 [patent_title] => 'Diazepan derivatives' [patent_app_type] => utility [patent_app_number] => 11/788252 [patent_app_country] => US [patent_app_date] => 2007-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54869 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/632/07632829.pdf [firstpage_image] =>[orig_patent_app_number] => 11788252 [rel_patent_id] =>[rel_patent_doc_number] =>)